The Federal Government is working with a multinational healthcare company, Roche and digital healthcare provider, Oncopadi Technologies, to launch a Breast Cancer Access Navigation and Testing (BRANT) Programme—an initiative aimed at supporting breast cancer patients across Nigeria.
The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 patients diagnosed with breast cancer.
Breast cancer is the most prevalent in Nigeria with over 32,000 cases yearly. Half of the women diagnosed with breast cancer do not survive beyond five years due to factors such as lack of awareness, insufficient funds, and limited access to testing and treatment in sub-Saharan Africa, including Nigeria, according to Roche.